Senate Spending Bills Give Minor Boost to FDA, Seek Price Disclosures in Ads

Instead of taking the usual August recess, the Senate stayed in Washington to approve several multi-agency budget bills for the government fiscal year that begins Oct. 1, 2018. The measures boost funding for FDA and the National Institutes of Health (NIH) and include a contentious provision thOriginal Article